<strong>Real-world study of patients with ER-positive and HER2-negative metastatic breast cancer receiving palbociclib combined with endocrine therapy</strong>

doi:10.3781/j.issn.1000-7431.2021.33.893

PDF(907 KB)

Tumor ›› 2021, Vol. 41 ›› Issue (05) : 309-317. DOI: 10.3781/j.issn.1000-7431.2021.33.893

Real-world study of patients with ER-positive and HER2-negative metastatic breast cancer receiving palbociclib combined with endocrine therapy

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2021, 41(05): 309-317 https://doi.org/10.3781/j.issn.1000-7431.2021.33.893

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

Funding

RIGHTS & PERMISSIONS

PDF(907 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Accepted	Published
2020-10-13	2021-05-10	2021-05-25
Issue Date
2021-05-25

Please choose a citation manager

Content to export

HeighLight

Abstract

Key words

QR code of this article

Cite this article

{{custom_sec.title}}

{{custom_sec.title}}

References

References

{{custom_fnGroup.title_en}}

Footnotes

{{custom_ack.title_en}}

Funding

RIGHTS & PERMISSIONS